Deciphera Pharmaceuticals, Inc. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/79be7ea5-0831-4ed2-96b2-b6fb2e70c003/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-211.0M | 2023-01-01 – 2023-12-31 | evidence 0001654151-24-000004 |
| FY 2022 | $-182.7M | 2022-01-01 – 2022-12-31 | evidence 0001654151-23-000003 |
| FY 2021 | $-300.1M | 2021-01-01 – 2021-12-31 | evidence 0001654151-22-000003 |
| FY 2020 | $-271.2M | 2020-01-01 – 2020-12-31 | evidence 0001654151-21-000003 |
| FY 2019 | $-200.7M | 2019-01-01 – 2019-12-31 | evidence 0001654151-20-000003 |
| FY 2018 | $-104.1M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-074791 |
| FY 2017 | $-50.9M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-099539 |
| FY 2016 | $-25.8M | 2016-01-01 – 2016-12-31 | evidence 0001193125-18-099539 |
| FY 2015 | $-17.6M | 2015-01-01 – 2015-12-31 | evidence 0001193125-18-099539 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Deciphera Pharmaceuticals, Inc. — all facts · Revenue · Net Income